#$%^&*AU2016200431B220170824.pdf#####Abstract The present invention relates to a substantially crystalline and free solid state form of 3-(6-(1 (2,2-difluorobenzo [d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin2yl)benzoic acid (Form I) of following formula: (I), pharmaceutical compositions thereof, and methods of treatment therewith. H(I)